Department of Otolaryngology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Eneas de Carvalho Aguiar 255, sala 6167, São Paulo 05403-000, SP, Brazil.
Sensors (Basel). 2024 Apr 27;24(9):2803. doi: 10.3390/s24092803.
(1) Background: Home sleep apnea testing, known as polysomnography type 3 (PSG3), underestimates respiratory events in comparison with in-laboratory polysomnography type 1 (PSG1). Without head electrodes for scoring sleep and arousal, in a home environment, patients feel unfettered and move their bodies more naturally. Adopting a natural position may decrease obstructive sleep apnea (OSA) severity in PSG3, independently of missing hypopneas associated with arousals. (2) Methods: Patients with suspected OSA performed PSG1 and PSG3 in a randomized sequence. We performed an additional analysis, called reduced polysomnography, in which we blindly reassessed all PSG1 tests to remove electroencephalographic electrodes, electrooculogram, and surface electromyography data to estimate the impact of not scoring sleep and arousal-based hypopneas on the test results. A difference of 15 or more in the apnea-hypopnea index (AHI) between tests was deemed clinically relevant. We compared the group of patients with and without clinically relevant differences between lab and home tests (3) Results: As expected, by not scoring sleep, there was a decrease in OSA severity in the lab test, similar to the home test results. The group of patients with clinically relevant differences between lab and home tests presented more severe OSA in the lab compared to the other group (mean AHI, 42.5 vs. 20.2 events/h, = 0.002), and this difference disappeared in the home test. There was no difference between groups in the shift of OSA severity by abolishing sleep scoring in the lab. However, by comparing lab and home tests, there were greater variations in supine AHI and time spent in the supine position in the group with a clinically relevant difference, either with or without scoring sleep, showing an impact of the site of the test on body position during sleep. These variations presented as a marked increase or decrease in supine outcomes according to the site of the test, with no particular trend. (4) Conclusions: In-lab polysomnography may artificially increase OSA severity in a subset of patients by inducing marked changes in body position compared to home tests. The location of the sleep test seems to interfere with the evaluation of patients with more severe OSA.
(1) 背景:与实验室多导睡眠图 1 型(PSG1)相比,家庭睡眠呼吸暂停测试(也称为多导睡眠图 3 型,PSG3)低估了呼吸事件。在家庭环境中,由于没有评分睡眠和觉醒的头部电极,患者感觉无拘无束,可以更自然地移动身体。采用自然体位可能会降低 PSG3 中的阻塞性睡眠呼吸暂停(OSA)严重程度,而与觉醒相关的呼吸暂停缺失无关。(2) 方法:怀疑患有 OSA 的患者以随机顺序进行 PSG1 和 PSG3 检查。我们进行了一项额外的分析,称为简化多导睡眠图,在该分析中,我们盲目重新评估了所有 PSG1 测试,以去除脑电图、眼电图和表面肌电图数据,以评估不评分睡眠和基于觉醒的呼吸暂停对测试结果的影响。如果测试之间的呼吸暂停低通气指数(AHI)差异为 15 或更多,则认为具有临床相关性。我们比较了实验室和家庭测试之间存在临床相关差异的患者组和不存在临床相关差异的患者组。(3) 结果:正如预期的那样,由于不评分睡眠,实验室测试中的 OSA 严重程度降低,与家庭测试结果相似。与另一组相比,实验室和家庭测试之间存在临床相关差异的患者组在实验室中表现出更严重的 OSA(平均 AHI,42.5 与 20.2 次/小时,= 0.002),而这种差异在家庭测试中消失了。在实验室中消除睡眠评分对 OSA 严重程度的变化没有组间差异。然而,通过比较实验室和家庭测试,在具有临床相关差异的组中,无论是否评分睡眠,仰卧位 AHI 和仰卧位时间的变化更大,表明测试部位对睡眠期间身体位置的影响。这些变化表现为根据测试部位的仰卧位结果的明显增加或减少,没有特定趋势。(4) 结论:与家庭测试相比,在实验室中进行多导睡眠图可能会通过引起与身体位置的显著变化来人为地增加一部分患者的 OSA 严重程度。睡眠测试的位置似乎会干扰对更严重 OSA 患者的评估。